Consolidated Statement Of Cash Flows

PhoenixBio Co.,Ltd. - Filing #7249745

Concept As at
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-97,504,000 JPY
-41,289,000 JPY
Interest and dividends received
7,952,000 JPY
5,970,000 JPY
Income taxes paid
-7,608,000 JPY
-49,157,000 JPY
Interest paid
-5,246,000 JPY
-2,927,000 JPY
Net cash provided by (used in) operating activities
-73,000,000 JPY
-79,307,000 JPY
Cash flows from investing activities
Purchase of securities
-418,000 JPY
-206,000 JPY
Purchase of property, plant and equipment
-21,243,000 JPY
-31,623,000 JPY
Purchase of investment securities
JPY
-9,062,000 JPY
Net cash provided by (used in) investing activities
-27,985,000 JPY
115,358,000 JPY
Other, net
8,093,000 JPY
10,001,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
JPY
400,000,000 JPY
Repayments of long-term borrowings
-79,992,000 JPY
-19,998,000 JPY
Net cash provided by (used in) financing activities
-128,000,000 JPY
-244,879,000 JPY
Effect of exchange rate change on cash and cash equivalents
-6,514,000 JPY
38,395,000 JPY
Net increase (decrease) in cash and cash equivalents
-235,500,000 JPY
-170,431,000 JPY
Cash and cash equivalents
1,149,390,000 JPY
1,384,891,000 JPY
1,555,323,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.